TG Therapeutics | Betriebsaufwand



Operating Expenses Veränderung Datum
AbbVie USD 16.59B 5.96B 2024-12
Alaunos Therapeutics USD 759K 391K 2024-12
Amgen USD 6.78B 401M 2024-12
Ardelyx USD 108M 12M 2024-12
Arrowhead Research USD 163.91M 1.71M 2024-12
Bayer EUR 8.2B 5.59B 2024-12
Biogen USD 2.01B 13.3M 2024-12
Corcept Therapeutics USD 156.63M 20.68M 2024-12
Dynavax Technologies USD 73.66M 3.12M 2024-12
Gilead Sciences USD 5.12B 1.54B 2024-12
J&J USD 8.26B 10.37B 2025-03
Novartis USD 11.28B 1.73B 2024-12
PTC Therapeutics USD 275.66M 24.36M 2024-12
Regeneron Pharmaceuticals USD 2.8B 26.53B 2024-12
Roche Holding CHF 11.43B 1.48B 2024-12
TG Therapeutics USD 78.24M 6.79M 2024-12
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12



TG Therapeutics Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.